AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CLARITHROMYCIN USP

10 registrations across 4 African markets— 5 active

Markets with CLARITHROMYCIN USP

Recent registrations

Brand / ProductMarketHolderStatusExpires
Clarithro 500mg tablets
Tablet, Filmcoated
🇿🇲ZambiaM/S Nabiqasim Industries (Pvt) LtdactiveJun 2031
Clariwin 500 tablets
Tablet Uncoated
🇿🇲ZambiaMICRO LABS LTDactiveAug 2030
ACEM-500
TABLETS
🇷🇼RwandaEMCURE PHARMACETICALS LTDactiveAug 2029
CLARICOS
Tablets
🇷🇼RwandaCOSMOS LIMITEDactiveAug 2029
CLARYL-500
TABLETS
🇷🇼RwandaUMEDICA LABORATORIES PVT. LTDactiveAug 2029
CLARET TABLETS
TABLET/ 2X7
🇳🇬NigeriaGLOBAL HEALTHCARE LTD NO. 3expiredJul 2021
OMECET PLUS COMBI KIT
CAPSULES/TABLETS/7 X2 COMBI KITS
🇳🇬NigeriaMAYDON PHARMACEUTICALS LTD 15expiredApr 2021
MACLAR-250 250MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2007
MACLAR-500 500MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2007
AZICLAR-500 500MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2007

CLARITHROMYCIN USP in Africa — Regulatory Overview

CLARITHROMYCIN USP is registered across 4 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Rwanda, Nigeria, Zambia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 5 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.